This week it became known about the successful trials of a vaccine from Pfizer and BioNTech. It has no side effects and is 90% effective in preventing COVID-19. The developers of the Russian Sputnik V vaccine, which has already been registered but is undergoing the third phase of clinical trials, decided to announce the effectiveness of their vaccine.
According to the specialists of the Center. Gamaleya and the Russian Direct Investment Fund, according to interim data from the third phase of trials, the effectiveness of the Russian vaccine made up 92%.
– The statistical analysis included 20 confirmed cases. Based on the distribution of 20 confirmed cases (identified in the placebo group and in the vaccine group), it was determined that the effectiveness of “Sputnik V” was 92%.
Russian volunteers began injecting the Russian vaccine in September. Since then, the number of study participants who received the first dose has reached 20,000. It is reported that no unexpected and undesirable reactions have been identified in them. This testing phase will last six months, and a final report will be made based on its results.
Earlier we wrote that in the West the scientific community reacted to the Russian vaccine with skepticism.